ES8608884A1 - Un procedimiento de eliminacion del virus lav. - Google Patents
Un procedimiento de eliminacion del virus lav.Info
- Publication number
- ES8608884A1 ES8608884A1 ES546974A ES546974A ES8608884A1 ES 8608884 A1 ES8608884 A1 ES 8608884A1 ES 546974 A ES546974 A ES 546974A ES 546974 A ES546974 A ES 546974A ES 8608884 A1 ES8608884 A1 ES 8608884A1
- Authority
- ES
- Spain
- Prior art keywords
- immunodepression
- syndrom
- lymphadenopathy
- protecting
- acquired
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 210000001744 T-lymphocyte Anatomy 0.000 title abstract 2
- 208000008771 Lymphadenopathy Diseases 0.000 title 1
- 208000018555 lymphatic system disease Diseases 0.000 title 1
- 208000011580 syndromic disease Diseases 0.000 title 1
- 241000700605 Viruses Species 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- External Artificial Organs (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
PROCEDIMIENTO PARA LA ELIMINACION DEL VIRUS LAV CONTENIDO EN EL PLASMA DE UN PACIENTE. CONSISTE EN HACER PASAR EL PLASMA AFECTADO POR UNA COLUMNA DE AFINIDAD QUE LLEVA MOLECULAS T4 Y EN RECOGER EL PLASMA LIBERADO DE VIRUS LAV. DICHA COLUMNA PORTADORA DE MOLECULAS T4 PUEDE SERVIR IGUALMENTE PARA ATRAPAR LOS ANTICUERPOS ANTI-T4 RESULTANTES DE UN MECANISMO AUTOINMUNITARIO IMPLICADOS EN LA ENFERMEDAD. LOS ANTICUERPOS ANTI-T4 ATRAPADOS DE ESTA MANERA, ESTAN CONSTITUIDOS EN GENERAL POR AUTOANTICUERPOS PRESENTE EN EL PLASMA. DE APLICACION EN LA PROTECCION DE LOS LINFOCITOS T CONTRA LOS AGENTES ETIOLOGICOS DE LAS LINFADENOPATIAS Y DEL SINDROME DE INMUNODEFICIENCIA ADQUIRIDA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8414172A FR2570278B1 (fr) | 1984-09-14 | 1984-09-14 | Compositions et procede pour proteger les lymphocytes t contre l'agent etiologique des lymphadenopathies et du syndrome d'immunodepression acquise |
Publications (2)
Publication Number | Publication Date |
---|---|
ES546974A0 ES546974A0 (es) | 1986-09-01 |
ES8608884A1 true ES8608884A1 (es) | 1986-09-01 |
Family
ID=9307750
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES546974A Expired ES8608884A1 (es) | 1984-09-14 | 1985-09-13 | Un procedimiento de eliminacion del virus lav. |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0176429B1 (es) |
JP (2) | JP2783403B2 (es) |
AT (1) | ATE58478T1 (es) |
CA (1) | CA1273304A (es) |
DE (2) | DE3580639D1 (es) |
ES (1) | ES8608884A1 (es) |
FR (1) | FR2570278B1 (es) |
OA (1) | OA08099A (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2592893A1 (fr) * | 1986-01-15 | 1987-07-17 | Pasteur Institut | Population de lymphocytes t4 specifiques du virus lav, leur procede d'obtention et leur application a la production de ce virus. |
IL83687A (en) * | 1987-08-30 | 1995-03-30 | Yeda Res & Dev | Pharmaceutical compositions comprising molecular decays and their use in the manufacture of said compositions |
AU2725988A (en) * | 1987-11-20 | 1989-06-14 | Upjohn Company, The | Derivatives of lincosaminide antibiotics |
JPH02502633A (ja) * | 1987-12-19 | 1990-08-23 | ラボラトリウム フュー エクスペリメンテル シルージー、フォーチュングスインスティチュート、ダフォス | 抗ウィルス性治療用組成物 |
DE3828582A1 (de) * | 1988-08-23 | 1990-03-01 | Max Planck Gesellschaft | Monoklonaler antikoerper zur inhibierung der infektion von zellen durch hiv-viren |
EP0408372A1 (en) * | 1989-07-13 | 1991-01-16 | Smithkline Beecham Corporation | Anti-viral therapy |
US5591448A (en) * | 1994-11-21 | 1997-01-07 | Tepic; Slobodan | Anti-viral therapeutic composition |
CN106075626B (zh) * | 2016-07-01 | 2018-06-26 | 浙江大学 | 一种艾滋病血液净化治疗仪 |
CN106166313B (zh) * | 2016-07-01 | 2018-09-07 | 浙江大学 | 一种艾滋病孕妇血液净化器 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4381295A (en) * | 1979-04-26 | 1983-04-26 | Ortho Pharmaceutical Corporation | Monoclonal antibody to human helper T cells and methods of preparing same |
FR2504010B1 (fr) * | 1981-04-15 | 1985-10-25 | Sanofi Sa | Medicaments anticancereux contenant la chaine a de la ricine associee a un anticorps antimelanome et procede pour leur preparation |
-
1984
- 1984-09-14 FR FR8414172A patent/FR2570278B1/fr not_active Expired
-
1985
- 1985-09-13 CA CA000490731A patent/CA1273304A/fr not_active Expired - Lifetime
- 1985-09-13 EP EP85401780A patent/EP0176429B1/fr not_active Expired - Lifetime
- 1985-09-13 ES ES546974A patent/ES8608884A1/es not_active Expired
- 1985-09-13 DE DE8585401780T patent/DE3580639D1/de not_active Expired - Lifetime
- 1985-09-13 JP JP60203239A patent/JP2783403B2/ja not_active Expired - Lifetime
- 1985-09-13 DE DE8989108697T patent/DE3583400D1/de not_active Expired - Lifetime
- 1985-09-13 AT AT85401780T patent/ATE58478T1/de not_active IP Right Cessation
- 1985-09-16 OA OA58679A patent/OA08099A/xx unknown
-
1996
- 1996-05-30 JP JP8137176A patent/JPH0912462A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA1273304A (fr) | 1990-08-28 |
JP2783403B2 (ja) | 1998-08-06 |
JPH0912462A (ja) | 1997-01-14 |
EP0176429A1 (fr) | 1986-04-02 |
JPS61143328A (ja) | 1986-07-01 |
FR2570278A1 (fr) | 1986-03-21 |
ES546974A0 (es) | 1986-09-01 |
ATE58478T1 (de) | 1990-12-15 |
DE3580639D1 (de) | 1991-01-03 |
DE3583400D1 (de) | 1991-08-08 |
FR2570278B1 (fr) | 1987-02-13 |
OA08099A (fr) | 1987-03-31 |
EP0176429B1 (fr) | 1990-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2861729D1 (en) | Aliphatic derivatives of phosphonoformic acid, pharmaceutical compositions and methods for combating virus infections | |
BG102048A (en) | Tetrahydrofuran-containing sulphonamides as aspartylprotease inhibitors | |
ES8307794A1 (es) | Un procedimiento para la preparacion de agentes antifugicos triazolicos. | |
EP0219876A3 (en) | Antihypertensive agents comprising 2-alkynyladenosines as active ingredients | |
IL74535A0 (en) | Antiviral pharmaceutical compositions containing lidocaine,method for preparation thereof and method of treating viral infections thereby | |
DE69811062D1 (de) | Polyaromatische antivirale zusammensetzungen | |
EP0508488A3 (en) | Use of inositol triphosphate for the treatment of diseases associated with metal intoxications | |
EP0230574A3 (en) | Pharmaceutical compositions against infections caused by lav/htlv iii virus and the use thereof | |
IE873125L (en) | Benzimidazole derivatives | |
EP0403251A3 (en) | Monokine activity interference | |
IL84790A (en) | Pharmaceutical compositions containing 3)-deoxythymidin-2)-ene (3)-deoxy-2), 3)-didehydrothymidine) for treating patients infected with retroviruses | |
ES8608884A1 (es) | Un procedimiento de eliminacion del virus lav. | |
MY106231A (en) | Antiviral tetrahydroimidazo [1,4] benzodiazepin-2- thiones. | |
JO1406B1 (en) | Chemical compounds | |
MY104942A (en) | Antiviral tetrahydroimidazo [1,4] benzodiazepin-2-ones. | |
IL121272A (en) | Pharmaceutical compositions comprising adenosine and their use for treating or preventing leukopenia | |
ES8605532A1 (es) | Un procedimiento para preparar derivados de aminoglicosido | |
ES2016464A6 (es) | Procedimiento para preparar derivados de 2', 5' -oligoadenilato. | |
ATE22282T1 (de) | Pentacycloundecan derivate, verfahren zu ihrer herstellung, und diese enthaltende pharmazeutische zusammensetzungen. | |
EP0335426A3 (en) | Compositions and process for protecting t lymphocytes against the etiological agent of lymphadenopathy and acquired immunodepression syndrom | |
JPS55113721A (en) | Immunity regulator | |
KR900017587A (ko) | 바이러스 감염증 치료제의 제조를 위한 티아졸 유도체 티프로티모드의 용도 | |
MY106961A (en) | Antiviral tetrahydroimidazo[1,4] benzodiazepines | |
ES2096559T3 (es) | Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso. | |
ZA896230B (en) | Pharmaceutical composition for inhibiting infection with virus causative of acquired human immunodefeciency syndrome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 20020506 |